Teva collaboration agreement aims to accelerate clinical data generation for TEV-56278 and develop Anti-PD1-IL2 Therapy.

Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the DNA-testing company after a nonprofit ...

Ecolab has launched a new resin designed to help achieve cost savings and optimize operations throughout the antibody ...

The collaboration aims to advance the discovery and development of novel oral candidates.

Merck also introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable locally advanced head ...

Mitsubishi Research Institute and Astellas have agreed on a memorandum of understanding to provide drug-discovery startups in ...

The research program will combine Debiopharm’s AbYlink conjugation technology with Alkyon’s modular antibody platform and ...

BioNTech has agreed to acquire CureVac, a clinical-stage biotech company developing a novel class of transformative medicines ...

Nuvation Bio Inc., a global oncology company, received U.S. Food and Drug Administration (FDA) approval of Ibtrozi ...

Novo Nordisk and Deep Apple Therapeutics Inc. have entered a research collaboration and exclusive license agreement.

PL BioScience GmbH, a German life science company, has appointed Oliver Dick, PhD, as Chief Technology Officer.

OncoACP3 is a small molecule ligand with high affinity and specificity for Acid Phosphatase 3 (ACP3), a novel target in ...